Literature DB >> 28400287

Anti-inflammatory and vasoconstrictive properties of Potentilla erecta - A traditional medicinal plant from the northern hemisphere.

Ute Wölfle1, Julia Hoffmann2, Birgit Haarhaus2, Venugopal Rao Mittapalli3, Christoph M Schempp2.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Potentilla erecta (L.) Raeusch is a medicinal plant of the Northern hemisphere belonging to the plant family of roses (Rosaceae). It has traditionally been used to treat inflammatory disorders of the skin and mucous membranes as well as chronic diarrhea. AIM OF THE STUDY: In the present study we analyzed the anti-inflammatory and vasoconstrictive effect of a Potentilla erecta extract (PE) and questioned if PE is similar effective as mild corticosteroids. Then we analyzed if PE acts in the skin via a similar mode of action as corticosteroids.
MATERIAL AND METHODS: The anti-inflammatory effect of PE was analyzed in irradiated HaCaT keratinocytes by measuring the formation of IL-6 and PGE2. Additionally the effect of PE on TNF-α induced NF-κB activation was determined. As the anti-inflammatory effect of corticosteroids correlates with their vasoconstrictive properties we tested if PE displays also vasoconstriction. Therefore we performed an occlusive patch test and a collagen contraction assay. Furthermore the binding of PE to the glucocorticoid receptor was determined with stainings and reporter assays. The interaction of PE on the nitric oxide (NO) content was examined with radical scavenging and endothelial NO synthase (eNOS) reporter assays.
RESULTS: In irradiated or TNF-α stimulated HaCaT cells the formation of IL-6 and PGE2 or NF-κB activation was strongly reduced by PE. Furthermore PE showed a blanching effect comparable to hydrocortisone. However, in contrast to glucocorticoids, PE did not cause nuclear translocation of the glucocorticoid receptor in HaCaT cells. The blanching effect of PE was at least partly attributable to a scavenging effect of NO and inhibition of eNOS.
CONCLUSIONS: PE displays anti-inflammatory and vasoconstrictive effects and might therefore be beneficial for the topical treatment of inflammatory skin disorders.
Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Agrimoniin; Glucocorticoid receptor; Keratinocytes; NO; Potentilla erecta; Vasoconstriction

Mesh:

Substances:

Year:  2017        PMID: 28400287     DOI: 10.1016/j.jep.2017.03.058

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  5 in total

Review 1.  COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy?

Authors:  Dâmaris Silveira; Jose Maria Prieto-Garcia; Fabio Boylan; Omar Estrada; Yris Maria Fonseca-Bazzo; Claudia Masrouah Jamal; Pérola Oliveira Magalhães; Edson Oliveira Pereira; Michal Tomczyk; Michael Heinrich
Journal:  Front Pharmacol       Date:  2020-09-23       Impact factor: 5.810

2.  Study of the Antimicrobial Activity of the Chinese Dong Ethnic Minority Medicine, Madeng'ai.

Authors:  Zhenrong Tang; Yannan Zhao; Zaiqi Zhang; Huan Yue; Dan Wang; Shengchun Liu; Hua Tang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-01       Impact factor: 2.650

Review 3.  Current Knowledge on Interactions of Plant Materials Traditionally Used in Skin Diseases in Poland and Ukraine with Human Skin Microbiota.

Authors:  Natalia Melnyk; Inna Vlasova; Weronika Skowrońska; Agnieszka Bazylko; Jakub P Piwowarski; Sebastian Granica
Journal:  Int J Mol Sci       Date:  2022-08-25       Impact factor: 6.208

4.  Contributing to Global Health: Development of a Consensus-Based Whole Systems Research Strategy for Anthroposophic Medicine.

Authors:  G S Kienle; E Ben-Arye; B Berger; C Cuadrado Nahum; T Falkenberg; G Kapócs; H Kiene; D Martin; U Wolf; H Szöke
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-12       Impact factor: 2.629

Review 5.  Secondary Metabolites of Plants as Modulators of Endothelium Functions.

Authors:  Anna Bartáková; Marie Nováková
Journal:  Int J Mol Sci       Date:  2021-03-03       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.